Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Regulatory News (COG)

Share Price Information for Cambridge Cog (COG)

Share Price is delayed by 15 minutes
Get Live Data
37.00    0.00 (0.00%)
Bid:
35.00
Ask:
39.00
Spread: 4.00 (11.429%)
Market Cap: £17.23m
COG Live PriceLast checked at - London Stock Exchange

Intraday Cambridge Cog Share Chart

Dr. Nick Kerton

14 Aug 2019 10:10

RNS Number : 0287J
Cambridge Cognition Holdings PLC
14 August 2019
 

Cambridge Cognition Holdings Plc

 

('Cambridge Cognition' or the 'Company')

 

Dr. Nick Kerton

 

 

Cambridge Cognition Holdings plc (AIM: COG) is deeply saddened to report the death of Nick Kerton, the Company's former Chief Executive Officer and Non-executive Director, after a long fight with cancer.

 

Dr. Kerton was first appointed to the Company's board on its Admission to AIM in May 2013 and became Chief Executive Officer in September 2013, a role he held until the end of 2015, before becoming one of the Company's Non-executive Directors. He retired from the board at the Company's AGM in April 2019.

 

Deepest sympathies from all at Cambridge Cognition have been conveyed to his family.

 

Steven Powell, Chairman of Cambridge Cognition, said: "We were saddened to learn of the passing of Nick. Everyone at the Company acknowledges the significant contribution he made to the development and leadership of the Company in his executive and non-executive roles, from the time of our IPO through to our recent AGM. Our thoughts are with Nick's family at this difficult time."

 

Enquiries

 

Cambridge Cognition Holdings PLC

Nick Walters, Chief Financial Officer

 

Tel: 01223 810 700

 

IFC Advisory Ltd (Financial PR and IR)

Tim Metcalfe

Tel: 020 3934 6630

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
NRALIFIATTISLIA
Date   Source Headline
18th Oct 20247:00 amRNSDirectorate Change
10th Oct 202412:44 pmRNSBlock Listing Return
12th Sep 202412:38 pmRNSDirectorate change
22nd Aug 20247:00 amRNSInterim Results
20th Aug 20247:00 amRNSNotice of Results
12th Aug 202412:15 pmRNSHolding(s) in Company
26th Jul 20247:00 amRNSIssue of Equity and Total Voting Rights
23rd Jul 20247:00 amRNSTrading Update & Board Change
11th Jul 20247:00 amRNSCambridge Cognition secures Innovate UK grant
1st Jul 20244:20 pmRNSHolding(s) in Company
1st Jul 20247:00 amRNSGrant of Options
28th Jun 20241:48 pmRNSResult of AGM & Change of Name of NOMAD & Broker
21st Jun 202411:23 amRNSHolding(s) in Company
20th Jun 20242:15 pmRNSHolding(s) in Company
20th Jun 20242:15 pmRNSHolding(s) in Company
17th Jun 202412:33 pmRNSResults of GM, Open Offer, TVR and PDMR Dealing
6th Jun 20247:00 amRNSNotice of AGM
31st May 20247:00 amRNSCircular Publication and Notice of General Meeting
30th May 20247:00 amRNSResult of Placing and Subscription
29th May 20244:39 pmRNSProposed Placing, Subscription and Open Offer
1st May 20247:00 amRNSPreliminary Results, Trading Update & Board Change
30th Apr 20247:00 amRNSNotice of Results
23rd Apr 20247:00 amRNSCOG spin-out Monument Therapeutics accesses £1.5m
2nd Apr 20244:20 pmRNSTotal Voting Rights and Block Listing Return
21st Mar 20247:00 amRNSFormation of new Scientific Advisory Board
21st Feb 202410:16 amRNSHolding(s) in Company
21st Feb 20247:00 amRNSCambridge Cognition and ActiGraph Partnership
30th Jan 20244:20 pmRNSDirector/PDMR Share Purchases
30th Jan 20247:00 amRNSBoard appointments
30th Jan 20247:00 amRNSTrading Update
18th Dec 20237:00 amRNSGrant of Options
1st Dec 20237:00 amRNSTotal Voting Rights
22nd Nov 20237:00 amRNSChange of Auditor
1st Nov 20237:00 amRNSTotal Voting Rights
24th Oct 20237:00 amRNSAutomated quality assurance for clinical trials
11th Oct 20237:00 amRNSMajor contract win combining solutions
5th Oct 20235:33 pmRNSIssue of Warrants
3rd Oct 20232:43 pmRNSBlock listing Interim Review
28th Sep 20233:35 pmRNSHolding(s) in Company
26th Sep 20237:01 amRNSInterim Results
26th Sep 20237:00 amRNSSecured £3 million Term Loan
4th Sep 20237:00 amRNSNotice of Interim Results
3rd Jul 20237:00 amRNSTotal Voting Rights
28th Jun 20234:26 pmRNSResult of AGM
13th Jun 20237:00 amRNS£2m contract for a pivotal cancer therapy trial
9th Jun 20237:00 amRNSNotice of AGM – Revision to Explanatory Note
6th Jun 20237:00 amRNSPosting of Annual Report & Notice of AGM
31st May 20237:00 amRNSCapital Markets Day
3rd May 20237:00 amRNSResults for the year ended 31 December 2022
26th Apr 20237:00 amRNSInvestor Webinar and Analyst Briefing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.